Expression Pathology Licenses Harvard’s AQUA Technology for Protein Quantification | GenomeWeb
NEW YORK (GenomeWeb News) - Expression Pathology said last week that it has licensed the patent rights to the AQUA protein quantification technology from Harvard University.
AQUA, a shortened form of “absolute quantification,” uses labeled peptide standards “to achieve absolute quantitation of target proteins in biological samples by mass spectrometry,” Expression Pathology said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.